Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of obstructive sleep apnea on outcomes after drug-eluting stent PCI in coronary artery disease
ChiCTR-TRC-12002673Phase 4Completed
- Sponsor
- Nanjing First Hospital
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Maximum platelet aggregation rate. Started Nov 2013; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002673.